Cardiff Oncology Inc
F:XE7C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cardiff Oncology Inc
F:XE7C
|
US |
|
N
|
NXP Semiconductors NV
XMUN:VNX
|
NL |
|
E
|
Elanco Animal Health Inc
F:5EA
|
US |
Shareholder Yield
Current shareholder yield for
XE7C is
.
Peers Comparison
Shareholder Yield
Price Appreciation
XE7C Price
Cardiff Oncology Inc
| Average Annual Return | 27.78% |
| Standard Deviation of Annual Returns | 129.18% |
| Max Drawdown | -88% |
| Market Capitalization | 112m EUR |
| Shares Outstanding | 44 737 200 |
| Percentage of Shares Shorted |
N/A
|
XE7C Return Decomposition
Main factors of price return
Stock Splits
XE7C's latest stock split occurred on Feb 20, 2019
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
Before the split, XE7C traded at 0.422 per share. Afterward, the share price was about 2.35.
The adjusted shares began trading on Feb 20, 2019. This was stock split number 3 in XE7C's history, following the previous one in Jun 4, 2018.